• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性间皮瘤的化疗:从阿霉素到长春瑞滨。

Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.

作者信息

Baas Paul

机构信息

Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

Semin Oncol. 2002 Feb;29(1):62-9. doi: 10.1053/sonc.2002.30231.

DOI:10.1053/sonc.2002.30231
PMID:11836670
Abstract

It has been a challenge to find effective chemotherapeutic treatments for malignant mesothelioma. Over the last several decades numerous single-drug and combination regimens have been examined, but no standard treatment with chemotherapy alone has emerged. Possible explanations for this lack of success are the heterogeneity between the different subclasses of mesothelioma and the difficulties experienced in determining responses on computed tomographic (CT) scan. This review will present the results of most chemotherapy trials. An attempt is also been made to overcome the problem of identifying the overall response rate by presenting the median survival time. Other types of response evaluation and guidelines for patient selection are warranted to properly compare chemotherapeutic treatments.

摘要

寻找有效的恶性间皮瘤化疗方案一直是一项挑战。在过去几十年里,人们对众多单药和联合用药方案进行了研究,但尚未出现仅用化疗的标准治疗方案。间皮瘤不同亚类之间的异质性以及在计算机断层扫描(CT)上确定反应所遇到的困难,可能是导致这种治疗失败的原因。本综述将呈现大多数化疗试验的结果。还尝试通过给出中位生存时间来克服确定总缓解率的问题。为了正确比较化疗方案,有必要采用其他类型的反应评估方法和患者选择指南。

相似文献

1
Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.恶性间皮瘤的化疗:从阿霉素到长春瑞滨。
Semin Oncol. 2002 Feb;29(1):62-9. doi: 10.1053/sonc.2002.30231.
2
Malignant mesothelioma--the UK experience.恶性间皮瘤——英国的经验
Lung Cancer. 2004 Aug;45 Suppl 1:S133-5. doi: 10.1016/j.lungcan.2004.04.024.
3
MVP and vinorelbine for malignant pleural mesothelioma.
Lancet. 2008 Aug 23;372(9639):629; author reply 629-30. doi: 10.1016/S0140-6736(08)61273-8.
4
Response to chemotherapy of brain metastases from malignant pleural mesothelioma.
Tumori. 1996 Sep-Oct;82(5):456-8. doi: 10.1177/030089169608200509.
5
Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.长春瑞滨联合顺铂或卡铂同步放化疗治疗局部晚期非小细胞肺癌(NSCLC)且治疗并发症风险增加的患者:初步结果
Strahlenther Onkol. 2003 Dec;179(12):823-31. doi: 10.1007/s00066-003-1127-8.
6
Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.长春瑞滨。其药理特性及在癌症化疗中的临床应用综述。
Drugs Aging. 1994 Sep;5(3):200-34. doi: 10.2165/00002512-199405030-00006.
7
Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.环磷酰胺、阿霉素和顺铂联合化疗治疗不可切除或转移性恶性胸膜间皮瘤的前瞻性研究
Cancer. 1995 Dec 1;76(11):2230-6. doi: 10.1002/1097-0142(19951201)76:11<2230::aid-cncr2820761108>3.0.co;2-2.
8
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.使用基于ATP的化学敏感性测定法来设计高浓度阿霉素与其他药物用于复发性卵巢癌的新组合。
Anticancer Drugs. 2002 Jul;13(6):625-30. doi: 10.1097/00001813-200207000-00009.
9
Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy.使用甲氨蝶呤和长春碱治疗恶性间皮瘤,联合或不联合铂类化疗。
Chest. 1996 May;109(5):1239-42. doi: 10.1378/chest.109.5.1239.
10
Chemotherapy for malignant pleural mesothelioma: past results and recent developments.恶性胸膜间皮瘤的化疗:既往结果与近期进展
Lung Cancer. 2004 Aug;45 Suppl 1:S103-19. doi: 10.1016/j.lungcan.2004.04.020.

引用本文的文献

1
Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.间皮瘤起始细胞的特征及其对抗癌药物的敏感性。
PLoS One. 2015 May 1;10(5):e0119549. doi: 10.1371/journal.pone.0119549. eCollection 2015.
2
Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.顺铂、培美曲塞和甲磺酸伊马替尼用于初治不可切除恶性胸膜间皮瘤患者的I期试验
Clin Lung Cancer. 2014 May;15(3):197-201. doi: 10.1016/j.cllc.2013.12.008. Epub 2013 Dec 27.
3
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
恶性胸膜间皮瘤诊断与治疗指南。
J Thorac Dis. 2013 Dec;5(6):E254-307. doi: 10.3978/j.issn.2072-1439.2013.11.28.
4
The cytotoxic effect of magainin II on the MDA-MB-231 and M14K tumour cell lines.抗菌肽Ⅱ对 MDA-MB-231 和 M14K 肿瘤细胞系的细胞毒性作用。
Biomed Res Int. 2013;2013:831709. doi: 10.1155/2013/831709. Epub 2013 Oct 9.
5
An epigenetic mechanism for capecitabine resistance in mesothelioma.一种用于间皮瘤中卡培他滨耐药的表观遗传机制。
Biochem Biophys Res Commun. 2010 Jan 15;391(3):1465-70. doi: 10.1016/j.bbrc.2009.12.095. Epub 2009 Dec 24.
6
Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.酪氨酸激酶抑制剂对恶性间皮瘤细胞增殖、迁移及基质金属蛋白酶产生的抑制作用
Neoplasia. 2004 Nov-Dec;6(6):705-12. doi: 10.1593/neo.04271.
7
Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register.影响间皮瘤患者长期生存的因素——德国间皮瘤登记处的结果
Int Arch Occup Environ Health. 2004 Apr;77(3):191-9. doi: 10.1007/s00420-003-0498-6. Epub 2004 Feb 27.
8
Advances in the management of malignant mesothelioma.恶性间皮瘤治疗进展
Curr Oncol Rep. 2003 Jul;5(4):334-41. doi: 10.1007/s11912-003-0076-9.
9
Current therapy for malignant mesothelioma.恶性间皮瘤的当前治疗方法。
Curr Oncol Rep. 2002 Jul;4(4):305-13. doi: 10.1007/s11912-002-0006-2.